AR064356A1 - Inhibidores benzoimidazolicos de trpv1 - Google Patents
Inhibidores benzoimidazolicos de trpv1Info
- Publication number
- AR064356A1 AR064356A1 ARP070105626A ARP070105626A AR064356A1 AR 064356 A1 AR064356 A1 AR 064356A1 AR P070105626 A ARP070105626 A AR P070105626A AR P070105626 A ARP070105626 A AR P070105626A AR 064356 A1 AR064356 A1 AR 064356A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- alkoxy
- 2amino
- cycloalkyl
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/12—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/50—1,3-Diazoles; Hydrogenated 1,3-diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Reivindicacion 1: Un compuesto de formula (1), y una de sus formas, en los cuales: las líneas punteadas entre las posiciones 1, 2 y 3 en la formula (1) indican las posiciones de un doble enlace tautomérico, en los cuales cuando se forma un doble enlace entre las posiciones 1 y 2, entonces R3b está presente, y en los cuales, cuando se forma un doble enlace entre las posiciones 2 y 3, entonces R3a está presente; p es 0, 1 o 2; q es 0, 1 o 2; r es 0, 1, 2 o 3; L es -X-alquilo C1-3- o -alquilo C1-3-Y-, donde cada caso del alquilo está perfluorado en forma opcional; X e Y son cada uno O, S, SO, SO2 o NR6; A1 se selecciona del grupo formado por indanilo, 1,2,3,4-tetrahidro-naftalenilo, fenilo, naftilo, benzo[1,3]dioxolilo, piridinilo y quinolinilo; R1 es hidrogeno, hidroxi, halogeno, alquilo C1-6, alcoxi C1-6, alquiltio C1-6, alquilsulfonilo C1-6, cicloalquilo C3-8, cicloalquil C3-8-alquilo C1-4, cicloalquil C3-8-alcoxi C1-4, cicloalquiloxi C3-8, amino, (alquil C1-6)1-2amino, (cicloalquil C3-8)1-2amino, (cicloalquil C3-8-alquil C1-4)1-2amino, ciano, alquilcarbonilo C1-6, alcoxicarbonilo C1-6, aminocarbonilo, (alquil C1-6)1-2aminocarbonilo, alquilcarbonilamino C1-6, aminocarbonil-alquilo C1-6, (alquil C16)1-2aminocarbonil- alquilo C1-6, alcoxi C1-6-aminocarbonil-alquilo C1-6, alcoxicarbonilamino C1-6, aminocarbonilamino, (alquil C1-6)1-2aminocarbonilamino, alquilsulfonilamino C1-6, aminosulfonilo o (alquil C1-4)1-2aminosulfonilo, donde cada caso del alquilo está sustituido en forma opcional con uno, dos o tres sustituyentes seleccionados en forma independiente del grupo formado por alcoxi C1-8, amino, (alquil C1-4)1-2amino, alquilcarbonilamino C1-6, alcoxicarbonilamino C1-6, aminocarbonilamino, (alquil C1- 6)1-2aminocarbonilamino, alquilsulfonilamino C1-6, halogeno, oxo e hidroxi, y en los cuales, cada caso del alquilo y el alcoxi está perfluorado en forma opcional; R2 se selecciona, cada uno, del grupo que consiste en halogeno, alquilo C1-4, alcoxi C1-4, alquilsulfonilo C1-4, nitro, (alquil C1-4)1-2amino y ciano, donde cada caso del alquilo y alcoxi está perfluorado en forma opcional; R3a y R3b se seleccionan, cada uno, del grupo que consiste en hidrogeno y alquilo C1-4; R4 es cada uno halogeno, nitro, ciano, alquilo C1-6, alcoxi C1-6, haloalquilo C1-6, haloalcoxi C1-6, alcoxi C1-6-alquilo C1-6, alquiltio C1-6, haloalquiltio C1-6, alquilsulfonilo C1-6, haloalquilsulfonilo C1-6, cicloalquilo C3-8, cicloalquil C3-8-alquilo C1-4, cicloalquil C3-8-alcoxi C1-4, cicloalquiloxi C3-8-, amino, (alquil C1-6)1-2amino, (cicloalquil C3-8)1-2amino, (cicloalquil C3-8-alquil C1-4)1-2amino, ciano, alquilcarbonilo C1-6, alcoxicarbonilo C1-6, alcoxicarbonil C1-6-alquilo C1-6, aminocarbonilo, (alquil C1-6)1-2aminocarbonilo, alquilcarbonilamino C1-6, alcoxicarbonilamino C1-6, aminocarbonilamino, (alquil C1-6)1-2aminocarboniIamino, alquilsulfonilamino C1-6, aminosulfonilo o (alquil C1-4)1-2aminosulfonilo, donde cada caso del alquilo y alcoxi está perfluorado en forma opcional; R5 se selecciona del grupo formado por halogeno, hidroxi, alquilo C1-4, haloalquilo C1-4, hidroxialquilo C1-4, alcoxi C1-4, alquilsulfonilo C1-4, nitro, alquilcarbonilo C1-6, alcoxicarbonilo C1-6, amino, (alquil C1-4)1-2amino, alquilcarbonilamino C1-6, alquilsulfonilamino C1-6, aminosulfonilo, (alquil C1-6)1-2aminosulfonilo y ciano, donde cada caso del alquilo y alcoxi está perfluorado en forma opcional; y R6 es un sustituyente seleccionado del grupo que consiste en hidrogeno y alquilo C1-4 perfluorado en forma opcional.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87021206P | 2006-12-15 | 2006-12-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR064356A1 true AR064356A1 (es) | 2009-04-01 |
Family
ID=39536675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070105626A AR064356A1 (es) | 2006-12-15 | 2007-12-14 | Inhibidores benzoimidazolicos de trpv1 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7612211B2 (es) |
| EP (1) | EP2124563B1 (es) |
| JP (1) | JP5746471B2 (es) |
| KR (1) | KR101503286B1 (es) |
| AR (1) | AR064356A1 (es) |
| AU (1) | AU2007333990A1 (es) |
| BR (1) | BRPI0721169A2 (es) |
| CA (1) | CA2672856C (es) |
| CL (1) | CL2007003636A1 (es) |
| ES (1) | ES2551709T3 (es) |
| MX (1) | MX2009006473A (es) |
| NZ (1) | NZ598485A (es) |
| PE (1) | PE20081383A1 (es) |
| TW (1) | TWI425943B (es) |
| UY (1) | UY30787A1 (es) |
| WO (1) | WO2008076752A1 (es) |
| ZA (1) | ZA200904920B (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7951829B2 (en) * | 2006-05-03 | 2011-05-31 | Janssen Pharmaceutica Nv | Benzimidazole modulators of VR1 |
| US20100144717A1 (en) * | 2006-12-15 | 2010-06-10 | Janelle Comita-Prevoir | 2-quinolinone and 2-quinoxalinone-derivatives and their use as antibacterial agents |
| CN101868443A (zh) | 2007-09-20 | 2010-10-20 | 特拉维夫大学拉莫特有限公司 | N-苯基邻氨基苯甲酸衍生物及其用途 |
| US8217060B2 (en) | 2009-05-15 | 2012-07-10 | Janssen Pharmaceutica, Nv | Benzimidazole derivatives useful as TRP M8 receptor modulators |
| EP2390245A1 (en) * | 2010-05-26 | 2011-11-30 | Nabriva Therapeutics AG | Enantiomerically pure amines |
| ES2786298T3 (es) | 2011-03-03 | 2020-10-09 | Zalicus Pharmaceuticals Ltd | Inhibidores de benzimidazol del canal de sodio |
| WO2013191112A1 (ja) | 2012-06-22 | 2013-12-27 | 住友化学株式会社 | 縮合複素環化合物 |
| EP2700431A1 (en) | 2012-08-24 | 2014-02-26 | AnalytiCon Discovery GmbH | Plant extracts for modulating TRPV1 function |
| LT6064B (lt) | 2012-10-15 | 2014-08-25 | Vilniaus Universitetas | Fluorinti benzensulfonamidai kaip karboanhidrazės inhibitoriai |
| EP3547991A1 (en) | 2016-12-02 | 2019-10-09 | Symrise AG | Cosmetic blends |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3182070A (en) | 1962-05-24 | 1965-05-04 | Dow Chemical Co | Benzimidazole compounds |
| FR2766822B1 (fr) * | 1997-07-30 | 2001-02-23 | Adir | Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US6299796B1 (en) | 1997-12-18 | 2001-10-09 | Fuji Photo Film Co., Ltd. | Styryl compound, method for the preparation thereof and electroluminescent element employing the same |
| US7144888B2 (en) | 2002-08-08 | 2006-12-05 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
| US20060172019A1 (en) * | 2003-03-07 | 2006-08-03 | Ralston Stuart H | Cannabinoid receptor inverse agonists and neutral antagonists as therapeutic agents for the treatment of bone disorders |
| AU2004285052A1 (en) * | 2003-10-31 | 2005-05-12 | Neurogen Corporation | 4-amino (AZA) quinoline derivatives as capsaicin receptor agonists |
| FR2880625B1 (fr) * | 2005-01-07 | 2007-03-09 | Sanofi Aventis Sa | Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique |
| WO2006078907A1 (en) * | 2005-01-20 | 2006-07-27 | Amgen Inc. | 2-substituted benzimidazole derivatives as vanilloid receptor ligands and their use in treatments |
| US7951829B2 (en) | 2006-05-03 | 2011-05-31 | Janssen Pharmaceutica Nv | Benzimidazole modulators of VR1 |
-
2007
- 2007-12-12 EP EP07865574.3A patent/EP2124563B1/en active Active
- 2007-12-12 JP JP2009541552A patent/JP5746471B2/ja active Active
- 2007-12-12 CA CA2672856A patent/CA2672856C/en active Active
- 2007-12-12 KR KR1020097014675A patent/KR101503286B1/ko active IP Right Grant
- 2007-12-12 WO PCT/US2007/087228 patent/WO2008076752A1/en active Application Filing
- 2007-12-12 ES ES07865574.3T patent/ES2551709T3/es active Active
- 2007-12-12 NZ NZ598485A patent/NZ598485A/xx unknown
- 2007-12-12 MX MX2009006473A patent/MX2009006473A/es active IP Right Grant
- 2007-12-12 BR BRPI0721169-4A patent/BRPI0721169A2/pt not_active IP Right Cessation
- 2007-12-12 AU AU2007333990A patent/AU2007333990A1/en not_active Abandoned
- 2007-12-12 US US11/954,647 patent/US7612211B2/en active Active
- 2007-12-13 PE PE2007001787A patent/PE20081383A1/es not_active Application Discontinuation
- 2007-12-13 UY UY30787A patent/UY30787A1/es unknown
- 2007-12-14 TW TW096147795A patent/TWI425943B/zh not_active IP Right Cessation
- 2007-12-14 AR ARP070105626A patent/AR064356A1/es not_active Application Discontinuation
- 2007-12-14 CL CL200703636A patent/CL2007003636A1/es unknown
-
2009
- 2009-07-14 ZA ZA200904920A patent/ZA200904920B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2672856A1 (en) | 2008-06-26 |
| US7612211B2 (en) | 2009-11-03 |
| UY30787A1 (es) | 2008-07-03 |
| TWI425943B (zh) | 2014-02-11 |
| ES2551709T3 (es) | 2015-11-23 |
| CA2672856C (en) | 2016-02-02 |
| EP2124563A4 (en) | 2011-04-20 |
| KR20090090386A (ko) | 2009-08-25 |
| EP2124563B1 (en) | 2015-07-29 |
| TW200843747A (en) | 2008-11-16 |
| EP2124563A1 (en) | 2009-12-02 |
| JP2010513298A (ja) | 2010-04-30 |
| MX2009006473A (es) | 2009-08-25 |
| CL2007003636A1 (es) | 2008-06-20 |
| JP5746471B2 (ja) | 2015-07-08 |
| ZA200904920B (en) | 2010-09-29 |
| WO2008076752A1 (en) | 2008-06-26 |
| NZ598485A (en) | 2013-08-30 |
| BRPI0721169A2 (pt) | 2014-03-18 |
| KR101503286B1 (ko) | 2015-03-17 |
| PE20081383A1 (es) | 2008-09-18 |
| AU2007333990A1 (en) | 2008-06-26 |
| US20080146637A1 (en) | 2008-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR064356A1 (es) | Inhibidores benzoimidazolicos de trpv1 | |
| CO6160329A2 (es) | Moduladores bencimidazolicos de vr1 | |
| AR056686A1 (es) | Derivados de diacilindazol como inhibidores de lipasas y fosfolipasas | |
| DK1807527T3 (da) | Stammer af yarrowia lipolytica, der producerer store mængder afarachidonsyre | |
| DK1926722T3 (da) | Substituerede benzimidazoler som kinaseinhibitorer | |
| DK1749011T3 (da) | Bicykliske heterocykler som HIV-integrasehæmmere | |
| AR055613A1 (es) | Formas cristalinas delta y epsilon de mesilato de imatinib | |
| DK2308419T3 (da) | Fremgangsmåde til bedømmelse af farvningstilstandene for dyresperm, som skal sorteres. | |
| DE602005004142D1 (de) | 4-hydroxy-4-methylpiperidin-1-carbonsäure-(4-methoxy-7-morpholin-4-ylbenzothiazol-2-yl)-amid | |
| AR059513A1 (es) | Derivados benzoil - piperidina como moduladores de 5ht/ d3 | |
| NO20080746L (no) | Urea-glukokinase-aktivatører | |
| DK1931350T3 (da) | Administration af inhibitorer af dipeptidylpeptidase | |
| NO20090313L (no) | Derivater og analoger av N-etylkinoloner og N-etylazakinoloner | |
| DK1981875T3 (da) | Substituerede indolylalkylaminoderivater som inhibitorer af histondeacetylase | |
| CL2010000395A1 (es) | Composicion farmaceutica que comprende dabigatran, inhibidor directo de la trombina y uno o mas inhibidores de plaquetas seleccionado entre clopidogrel y ticlopidina; y su uso para tratar enfermedades tales como trombosis venosa profunda y embolia pulmonar, entre otros eventos troboticos.8divisional de la solictud 687-06) | |
| DK1776136T3 (da) | Behandling af tilstande, der involverer demyelinisering | |
| DE602005011364D1 (de) | Faserlaser | |
| AT503451B8 (de) | Festkörperlaser | |
| AR055666A1 (es) | Inhibidores inntr | |
| AR054132A1 (es) | Derivados de azolopiridin-2-ona como inhibidores de lipasas y fosfolipasas | |
| BRPI0908791A2 (pt) | Nafto-piranos fotocrômicos dicróicos ópticos contendo os mesmos | |
| AR060937A1 (es) | Compuestos biciclicos sustituidos con sulfonilo como moduladores de ppar | |
| ES2396795T8 (es) | Compuesto de sulfonamida y cristal del mismo | |
| DK1912649T3 (da) | Quinolinderivater som antibakterielle midler | |
| AR056454A1 (es) | Mezclas pesticidas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |